Olga Carmona
Avila, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: April 15, 2026
Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: April 05, 2026
Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge.
Journal: Journal of personalized medicine
Published: February 25, 2026
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.
Journal: Frontiers in psychiatry
Published: January 22, 2025
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 14, 2024
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.
Journal: Patient preference and adherence
Published: January 12, 2024
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: January 03, 2024
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Journal: Journal of clinical medicine
Published: September 15, 2023
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.
Journal: Patient preference and adherence
Published: March 04, 2023
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: November 22, 2022
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: April 08, 2022
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: February 24, 2022
Last Updated: 09/26/2026